Drug General Information (ID: DDILW69TUC)
  Drug Name Didanosine Drug Info Lopinavir Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Anti-Hiv Agents Anti-Hiv Agents
  Structure

 Mechanism of Didanosine-Lopinavir Interaction (Severity Level: Moderate)
     Complex formation Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Didanosine Lopinavir
      Mechanism Polyvalent cations Binds to polyvalent cations
      Key Mechanism Factor 1
Factor Name Chelation
Factor Description Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption.
      Mechanism Description
  • Decreased absorption of Didanosine due to formation of complexes caused by Lopinavir 

Recommended Action
      Management When prescribed in combination with lopinavir-ritonavir oral solution, didanosine should be administered on an empty stomach one hour before or two hours after lopinavir-ritonavir oral solution, which is to be taken with food. Lopinavir-ritonavir tablets can be administered simultaneously with didanosine without food.

References
1 Canadian Pharmacists Association.
2 Cato A, Qian J, Carothers L, et al. "Evaluation of the pharmacokinetic interaction between ritonavir and didanosine." Clin Pharmacol Ther 59 (1996): 144. [PMID: 9715843]
3 Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.